BAY1237592
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY1237592, covering 2025-05-07 to 2025-05-07. Get the full timeline:
Most recent: Clinical Trial Update: This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) [Phase 1]